Statistics from Altmetric.com
Christopher P. Austin, MD, has been named as director of the National Institutes of Health’s (NIH’s) newest center, the National Center for Advancing Translational Sciences (NCATS). Dr. Austin has been serving as director of NCATS Division of Pre-Clinical Innovation since the center was launched in December 2011. He succeeds NCATS Acting Director Thomas R. Insel, MD. As Director, Dr. Austin will lead NCATS research initiatives, including the Clinical and Translational Science Awards. The Office of Rare Diseases Research, the NIH’s Chemical Genomics Center (NCGC) and the Therapeutics for Rare and Neglected Diseases (TRND) are also among NCATS’ programs.
Dr. Austin joined the NIH in 2002 as senior advisor to the director for translational research at the National Human Genome Research Institute (NHGRI), prior to which his work focused on genome-based discovery of novel targets and drugs at Merck. While at the NHGRI, he began the Knockout Mouse Project and the Molecular Libraries Roadmap Initiative. During his tenure at NIH, he has also served as the director of TRND and the NCGC and as scientific director of the NIH’s Center for Translational Therapeutics.
Dr. Austin earned his MD from Harvard Medical School. He completed clinical training in internal medicine and neurology at the Massachusetts General Hospital and a fellowship in genetics at Harvard.
Texas Medical Center Names President and CEO
Robert (Bobby) Robbins, MD, has been named president and CEO of Texas Medical Center (TMC) in Houston. His appointment was effective in November this year. Prior to joining TMC, Dr. Robbins served as a professor and chairman of the Department of Cardiothoracic Surgery at Stanford University and was director of the Stanford Cardiovascular Institute. He served on the faculty at Stanford since 1993.
A leading cardiothoracic surgeon, Dr. Robbins …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.